HEXASIIL – Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA), Poliomyelitis (Inactivated) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed)

HEXASIIL® is indicated for active immunization of infants, at or above the age of 6 weeks against Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis and invasive diseases caused by Haemophilus influenzae type b for 3 dose regimen (6, 10 & 14 Weeks) for primary vaccination and booster dose at the age of 12-24 months
Primary vaccination:
For active immunization of infants, it is recommended that 3 doses of 0.5 ml to be administered with an interval of at least four weeks between doses, starting at six weeks of age.
In countries where perinatal transmission of hepatitis B virus (HBV) is common, the first dose of HBV should be given as soon as possible after birth. In this case, HEXASIIL® can be used to complete the primary series from 6 weeks of age.
Booster vaccination:
A booster dose of DTP, Hib, and IPV should be given preferably during the second year of life (≥ 6 months after the last primary dose). Booster doses should be given under the official recommendations. A booster dose may be provided to children who have received primary vaccination of HEXASIIL® or any other DTP-containing vaccine and Poliomyelitis Vaccine (OPV and/or IPV).